When researchers studied 31,000 patients with diabetes who received
insurance and healthcare through Kaiser Permanente in Northern
California, they found that about 60 percent of Spanish-speaking
Latino patients skipped filling prescriptions at least 20 percent of
the time in the two years after they were told they needed the drugs
to help control the disease.
That rate was only about 52 percent among English-speaking Latino
patients and 38 percent among white patients.
“Latino patients with diabetes, even when insured and facing
relatively low barriers to healthcare, are much more likely to have
poor medication adherence than their white counterparts,” said lead
study author Dr. Alicia Fernandez, a researcher at San Francisco
General Hospital and the University of California, San Francisco.
The study didn’t find any difference in medication adherence for
diabetics with limited English based on whether they saw
Spanish-speaking doctors.
This suggests factors beyond just language and communication may
come into play, researchers conclude in JAMA Internal Medicine.
“Physicians who care for Latino patients with diabetes should focus
on medication adherence and explore individual barriers to
adherence,” Fernandez added by email. “These may include lack of
'buy-in' to medication treatment, concern regarding side effects,
concerns regarding costs, and competing life demands on medication
use and self-care.”
But while this study didn’t find that having Spanish-speaking
doctors improved medication adherence, a separate study of Latino
diabetics published in the same journal did see some benefit.
The researchers on the second study also looked at data from Kaiser
Permanente, in this case to see whether patients with limited
English proficiency might have better blood sugar control when they
switched from English-speaking to Spanish-speaking primary care
physicians.
This study included about 1,600 Latino patients who preferred
speaking Spanish to English.
At the start of the study, 54 percent of these patients saw a
primary care provider who didn’t speak Spanish. During the study, 48
percent of this group of patients switched to a Spanish-speaking
doctor.
After this switch to Spanish-speaking doctors, 74 percent of these
patients had blood sugar in a healthy range, up from 63 percent when
they saw English-speaking doctors. This increase was 10 percent more
than the patients who just switched from one English-speaking doctor
to another.
[to top of second column] |
“Having a primary care provider that speaks your language appears to
be important for several reasons; it improves lines of
communication, may reduce the risk of misunderstandings, increases
patient satisfaction and now there is evidence that it may also
improve management of diabetes,” said lead study author Melissa
Parker, a researcher at Kaiser Permanente in Oakland, California.
Both studies have some limitations, including the lack of data on
some factors that can influence how much patients take their
medicine or follow advice from doctors, such as health literacy or
the degree of spoken or written abilities in English and Spanish for
physicians and patients.
Still, the results from these studies suggest that it would make
sense to prioritize access to Spanish-speaking doctors for Latinos
with limited English who are newly diagnosed with diabetes, Dr.
Eliseo Pérez-Stable, director of the National Institute on Minority
Health and Health Disparities, writes in an accompanying editorial.
That’s because seeing a doctor who speaks Spanish may be more
important for establishing a treatment regimen than maintaining one,
Pérez-Stable writes.
“Communication between clinicians and patients is essential in most
aspects of medicine but it is especially true in management of a
chronic disease such as diabetes,” Pérez-Stable said by email.
Ideally, there would be more Spanish-speaking and bilingual doctors,
Pérez-Stable added by email. Absent that, patients should make sure
there’s a professional interpreter available and also bring someone
to clinic visits who is bilingual and can help support the treatment
plan after patients go home.
SOURCE: http://bit.ly/2iXRiVw, http://bit.ly/2jqDjDJ and http://bit.ly/2jL3eqG
JAMA Internal Medicine, online January 23, 2017.
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |